FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152463906> ?p ?o ?g. }

• W2152463906 endingPage "769" @default.
• W2152463906 startingPage "759" @default.
• W2152463906 abstract "Diabetes mellitus increases cardiovascular disease risk in humans and remains elevated despite cholesterol-lowering therapy with statins. Consistent with this, in mouse models, diabetes mellitus impairs atherosclerosis plaque regression after aggressive cholesterol lowering. MicroRNA 33 (miR33) is a key negative regulator of the reverse cholesterol transport factors, ATP-binding cassette transporter A1 and high-density lipoprotein, which suggested that its inhibition may overcome this impairment.To assess the effects of miR33 inhibition on atherosclerosis regression in diabetic mice.Reversa mice, which are deficient in the low-density lipoprotein receptor and in which hypercholesterolemia is reversed by conditional inactivation of the microsomal triglyceride transfer protein gene, were placed on an atherogenic diet for 16 weeks, then either made diabetic by streptozotocin injection or kept normoglycemic. Lipid-lowering was induced by microsomal triglyceride transfer protein gene inactivation, and mice were treated with anti-miR33 or control oligonucleotides. Although regression was impaired in diabetic mice treated with control oligonucleotides, anti-miR33 treatment decreased plaque macrophage content and inflammatory gene expression in these mice. The decreased macrophage content in anti-miR33 treated diabetic mice was associated with a blunting of hyperglycemia-induced monocytosis and reduced monocyte recruitment to the plaque, which was traced to an inhibition of the proliferation of bone marrow monocyte precursors associated with the upregulation of their Abca1.miR33 inhibition overcomes deleterious effects of diabetes mellitus in atherosclerosis regression in mice, which suggests a therapeutic strategy in diabetic patients, who remain at elevated cardiovascular disease risk, despite plasma cholesterol lowering." @default.
• W2152463906 created "2016-06-24" @default.
• W2152463906 creator A5002546631 @default.
• W2152463906 creator A5015450319 @default.
• W2152463906 creator A5016046871 @default.
• W2152463906 creator A5016463897 @default.
• W2152463906 creator A5022156816 @default.
• W2152463906 creator A5035258831 @default.
• W2152463906 creator A5065965634 @default.
• W2152463906 creator A5075712626 @default.
• W2152463906 creator A5088448170 @default.
• W2152463906 date "2014-10-10" @default.
• W2152463906 modified "2023-09-27" @default.
• W2152463906 title "miR33 Inhibition Overcomes Deleterious Effects of Diabetes Mellitus on Atherosclerosis Plaque Regression in Mice" @default.
• W2152463906 cites W1969694035 @default.
• W2152463906 cites W1970845955 @default.
• W2152463906 cites W1971924360 @default.
• W2152463906 cites W2002072152 @default.
• W2152463906 cites W2031622072 @default.
• W2152463906 cites W2038315143 @default.
• W2152463906 cites W2044161694 @default.
• W2152463906 cites W2048481833 @default.
• W2152463906 cites W2049878977 @default.
• W2152463906 cites W2052554962 @default.
• W2152463906 cites W2057651652 @default.
• W2152463906 cites W2064255959 @default.
• W2152463906 cites W2071884718 @default.
• W2152463906 cites W2075728036 @default.
• W2152463906 cites W2079724669 @default.
• W2152463906 cites W2095854838 @default.
• W2152463906 cites W2101743241 @default.
• W2152463906 cites W2103714932 @default.
• W2152463906 cites W2111505871 @default.
• W2152463906 cites W2115872041 @default.
• W2152463906 cites W2116643669 @default.
• W2152463906 cites W2128924195 @default.
• W2152463906 cites W2129126919 @default.
• W2152463906 cites W2130035132 @default.
• W2152463906 cites W2132243176 @default.
• W2152463906 cites W2137475525 @default.
• W2152463906 cites W2141554996 @default.
• W2152463906 cites W2143004078 @default.
• W2152463906 cites W2145899814 @default.
• W2152463906 cites W2147537648 @default.
• W2152463906 cites W2160264312 @default.
• W2152463906 cites W2166118660 @default.
• W2152463906 cites W2167453223 @default.
• W2152463906 cites W2167509693 @default.
• W2152463906 cites W2168964544 @default.
• W2152463906 cites W2169384530 @default.
• W2152463906 cites W2170942247 @default.
• W2152463906 cites W2331274940 @default.
• W2152463906 doi "https://doi.org/10.1161/circresaha.115.304164" @default.
• W2152463906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4194153" @default.
• W2152463906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25201910" @default.
• W2152463906 hasPublicationYear "2014" @default.
• W2152463906 type Work @default.
• W2152463906 sameAs 2152463906 @default.
• W2152463906 citedByCount "91" @default.
• W2152463906 countsByYear W21524639062014 @default.
• W2152463906 countsByYear W21524639062015 @default.
• W2152463906 countsByYear W21524639062016 @default.
• W2152463906 countsByYear W21524639062017 @default.
• W2152463906 countsByYear W21524639062018 @default.
• W2152463906 countsByYear W21524639062019 @default.
• W2152463906 countsByYear W21524639062020 @default.
• W2152463906 countsByYear W21524639062021 @default.
• W2152463906 countsByYear W21524639062022 @default.
• W2152463906 countsByYear W21524639062023 @default.
• W2152463906 crossrefType "journal-article" @default.
• W2152463906 hasAuthorship W2152463906A5002546631 @default.
• W2152463906 hasAuthorship W2152463906A5015450319 @default.
• W2152463906 hasAuthorship W2152463906A5016046871 @default.
• W2152463906 hasAuthorship W2152463906A5016463897 @default.
• W2152463906 hasAuthorship W2152463906A5022156816 @default.
• W2152463906 hasAuthorship W2152463906A5035258831 @default.
• W2152463906 hasAuthorship W2152463906A5065965634 @default.
• W2152463906 hasAuthorship W2152463906A5075712626 @default.
• W2152463906 hasAuthorship W2152463906A5088448170 @default.
• W2152463906 hasBestOaLocation W21524639062 @default.
• W2152463906 hasConcept C126322002 @default.
• W2152463906 hasConcept C134018914 @default.
• W2152463906 hasConcept C2778163477 @default.
• W2152463906 hasConcept C2778913445 @default.
• W2152463906 hasConcept C2779280383 @default.
• W2152463906 hasConcept C2780072125 @default.
• W2152463906 hasConcept C555293320 @default.
• W2152463906 hasConcept C71924100 @default.
• W2152463906 hasConceptScore W2152463906C126322002 @default.
• W2152463906 hasConceptScore W2152463906C134018914 @default.
• W2152463906 hasConceptScore W2152463906C2778163477 @default.
• W2152463906 hasConceptScore W2152463906C2778913445 @default.
• W2152463906 hasConceptScore W2152463906C2779280383 @default.
• W2152463906 hasConceptScore W2152463906C2780072125 @default.
• W2152463906 hasConceptScore W2152463906C555293320 @default.
• W2152463906 hasConceptScore W2152463906C71924100 @default.
• W2152463906 hasIssue "9" @default.
• W2152463906 hasLocation W21524639061 @default.

• next